Company Filing History:
2 out of 14 
1 out of 2,405 
Years Active: 2016-2022
Title: Innovations of Changmao Shen in Pharmaceutical Research
Introduction
Changmao Shen is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific diseases. With a total of three patents to his name, Shen's work focuses on innovative solutions for treating cancer and other related conditions.
Latest Patents
Changmao Shen's latest patents include groundbreaking compounds that inhibit ErbB and BTK. These compounds are designed to target mutant forms of ErbBs, such as EGFR and Her 2, along with BTK. The patents disclose pharmaceutically acceptable salts, hydrates, solvates, or stereoisomers of these compounds, as well as pharmaceutical compositions that can effectively treat diseases associated with ErbBs and BTK, including various forms of cancer.
Career Highlights
Throughout his career, Changmao Shen has worked with notable companies in the pharmaceutical industry. He has been associated with Dizal Pharmaceutical Co., Ltd. and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to develop and refine his innovative approaches to drug development.
Collaborations
Changmao Shen has collaborated with several professionals in his field, including Zhengtao Li and Hao Zou. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Changmao Shen's contributions to pharmaceutical research through his innovative patents highlight his commitment to addressing critical health challenges. His work continues to pave the way for new treatments in the fight against cancer and other diseases.